Gilles Vassal

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Christophe Massard, Stefan Michiels, Charles Ferté et al. · Cancer Discovery · 2017 · 747 citations

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson et al. · The Lancet Oncology · 2017 · 334 citations · Full text

Oncology, Medicine, Versus Carboplatin +8

Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

Fabrice André, Bastien Job, Philippe Dessen et al. · Clinical Cancer Research · 2009 · 329 citations

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Véronique Minard‐Colin, Anne Aupérin, Marta Pillon et al. · New England Journal of Medicine · 2020 · 298 citations · Full text

Differentiated Thyroid Carcinoma in Childhood: Long Term Follow-Up of 72 Patients

Martin Schlumberger, Florent de Vathaire, J P Travagli et al. · The Journal of Clinical Endocrinology & Metabolism · 1987 · 251 citations